Stock UniverseDerived research view · source repositories remain read-only

Stryker Corporation (SYK)

Life Science Tools / Diagnostics / MedTech · Healthcare / Medical Devices
Score Band
Very High
Selection Score
52.36
Global Rank
32
Market Cap
148.28B
Latest Close
305.66
RS Composite
-15.46% · G#2411

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
4.56%
3M
-15.93%
6M
-16.04%
1Y
-19.33%
3Y
14.19%
5Y
26.09%
10Y
207.30%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 2.12M · 30-day average: 2.98M · Max drawdown over stored range: -43.80%

Research Snapshot

Relative Strength vs SPX

RS Composite-15.46%
20D RS3.25%
60D RS-20.34%
120D RS-19.95%
Global RS Rank2411 · 28.14% percentile
Qualified+ RS Rank913 · 27.42% percentile
Group ScopeQualified+
Primary RS Rank92 · 35.21% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank4 / 246
Primary Percentile98.78
Score Notesmarket-cap support, industry-tailwind, category-leader

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-05-1125.27B16.13B4.99B3.34B8.636.99B1.23B5.75B387M63.83%19.74%13.21%27.65%22.77%2.88B14.22B

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$8.6335.4x$65.384.7x$14.8820.5x$18.0716.9x

Shares Diluted: 387M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue1710818449204982259525116
Revenue Growth (YoY)19.211%7.838%11.106%10.23%11.157%
Gross Profit1126211646130971454516336
Operating Income36563553411449565756
Free Cash Flow27382036313634874283
Free Cash Flow Per Share7.1625.3278.1739.04311.082
EPS (Diluted) GAAP5.216.178.257.768.4
EPS Growth24.048%18.426%33.712%-5.939%8.247%
EPS Non-GAAP
Gross Margin65.829%63.125%63.894%64.373%65.042%
Operating Margin21.37%19.258%20.07%21.934%22.918%
Profit Margin11.655%12.781%15.441%13.246%12.924%
Free Cash Flow Margin16.004%11.036%15.299%15.433%17.053%
Shares Outstanding (Diluted)382.3382.2383.7385.6386.5
Shares Change (YoY)0.526%-0.026%0.392%0.495%0.233%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-116.02B63.29%936.00M15.55%745.00M12.38%1.93386.50M2.88B14.22Bprocessed
2025 Q42026-02-117.17B64.54%1.80B25.16%849.00M11.84%2.20386.50M4.76B14.86Bprocessed
2025 Q32025-10-316.06B63.60%1.14B18.74%859.00M14.18%2.22386.70M3.26B14.85Bprocessed
2025 Q22025-08-016.02B63.78%1.11B18.48%884.00M14.68%2.29386.40M2.38B14.83Bprocessed
2025 Q12025-05-025.87B63.83%837.00M14.27%654.00M11.15%1.69386.40M2.32B14.38Bprocessed
2024 Q42025-02-126.44B64.85%581.00M9.03%546.00M8.48%1.41386.20M4.40B12.19Bprocessed
2024 Q32024-10-305.49B64.02%1.08B19.75%834.00M15.18%2.16385.60M3.85B13.32Bprocessed
2024 Q22024-07-315.42B63.00%1.05B19.38%825.00M15.22%2.14385.40M1.87B10.13Bprocessed
2024 Q12024-05-015.24B63.57%972.00M18.54%788.00M15.03%2.05385.10M2.33B10.81Bprocessed
2023 Q42024-02-145.82B63.68%1.26B21.62%1.14B19.66%2.98383.70M2.97B10.90Bprocessed
2023 Q32023-11-034.91B64.33%931.00M18.97%692.00M14.10%1.80384.00M1.86B10.38Bprocessed
2023 Q22023-08-045.00B63.67%965.00M19.32%738.00M14.77%1.93383.90M1.40B11.15Bprocessed
2023 Q12023-05-024.78B63.12%735.00M15.38%592.00M12.39%1.54383.20M1.67B11.86Bprocessed
2022 Q42023-02-105.20B62.21%814.00M15.65%563.00M10.82%1.47382.20M1.84B11.86Bprocessed
2022 Q32022-11-014.48B62.11%808.00M18.04%816.00M18.22%2.14381.80M1.42B12.75Bprocessed
2022 Q22022-07-274.49B62.90%772.00M17.18%656.00M14.60%1.72382.20M1.04B13.37Bprocessed
2022 Q12022-04-294.28B63.95%447.00M10.46%323.00M7.56%0.84382.70M1.46B13.88Bprocessed
2021 Q42022-02-114.70B64.77%819.00M17.42%662.00M14.08%1.73382.30M2.94B12.47Bprocessed
2021 Q32021-10-294.16B63.51%574.00M13.80%438.00M10.53%1.14382.70M2.56B12.63Bprocessed
2021 Q22021-07-284.29B64.56%732.00M17.05%592.00M13.79%1.55382.30M2.24B14.23Bprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.